Lyricbiomain

Developer of tissue-engineered bioreactors for manufacturing human immunoglobulin products

placeCambridge, Massachusetts, United States calendar_todayFounded 2018 language lyricbio.com

Social engagement

Social engagement: 1.1K social following, 8 posts in the last 12 months — above the industry median.

Investor mix

6 investors on record; lead investors include The Venture Collective.

Investor typeCountShare
Venture capital583%
Other / undisclosed117%

Hiring activity

Hires occasionally

3 roles tracked across 1 of the last 12 months

9 Dec 2025 · research scientist, scientist

9 Dec 2025 · optical engineer

11 Aug 2025 · research scientists

Based on job postings tracked across public sources.

Recent activity

11 Jun 2026
Recognition
3 Dec 2025
Partnership
Meiji Seika Pharma
Coming soon